Shingles, also known as herpes zoster, is a viral infection caused by the varicella-zoster virus, which also causes chickenpox (Centers for Disease Control and Prevention, 2022). After recovering from chickenpox, the virus remains dormant in nerve cells and can reactivate as shingles, typically in people over 50 (Mayo Clinic, 2022). Adults aged 60 and older are most susceptible to shingles, with the majority of cases occurring in this age group (National Institute on Aging, 2022). People with weakened immune systems, such as those with cancer, HIV/AIDS, or taking immunosuppressive medications, are also at increased risk. Shingles can be contracted anywhere, but it's most commonly spread through contact with an infected person's rash, making households and healthcare settings the most likely places to contract the disease.
Identification and Symptoms
Shingles typically starts with a burning or tingling sensation, followed by a rash, usually on one side of the body (National Institute on Aging, 2022). The rash develops into painful blisters that crust over and heal within 2-4 weeks. Other symptoms may include fever, headache, fatigue, and sensitivity to light. In some cases, shingles can cause eye problems, such as blurred vision or sensitivity to light, if the rash appears on the face (Mayo Clinic, 2022). Early identification and treatment can help prevent complications.
Treatment
While there is no cure for shingles, antiviral medications like acyclovir, valacyclovir, or famciclovir can reduce symptoms and duration (Centers for Disease Control and Prevention, 2022). Pain relief medications and cool compresses can also help manage symptoms. Additionally, topical creams or patches containing capsaicin or lidocaine may be prescribed to relieve pain, and antihistamines or corticosteroids may be used to reduce itching and inflammation. It's essential to consult a healthcare professional for proper diagnosis and treatment to minimize the risk of complications.
Prevention
The shingles vaccine, recommended for adults 50 and older, can significantly reduce the risk of developing shingles and its potential long-term complication, postherpetic neuralgia (PHN). PHN is a chronic condition characterized by persistent nerve pain that can last for months or even years after the shingles rash has healed. By getting vaccinated, individuals can lower their risk of developing shingles by 51% and PHN by 67% (Centers for Disease Control and Prevention, 2022). Additionally, practicing good hygiene, such as frequent handwashing, and maintaining a healthy immune system can also help prevent the spread of the virus.
References:
Centers for Disease Control and Prevention. (2022). Shingles (Herpes Zoster).
Mayo Clinic. (2022). Shingles.
National Institute on Aging. (2022). Shingles.
Centers for Disease Control and Prevention. (2022). Shingles Vaccine. Assessed and Endorsed by the MedReport Medical Review Board
Comments